Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Factors Influencing Hepatitis B Virus Reactivation in Lymphoma Patients Treated With Rituximab

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified January 2013 by Samsung Medical Center.
Recruitment status was:  Active, not recruiting
Sponsor:
Information provided by (Responsible Party):
Won Seog Kim, Samsung Medical Center
ClinicalTrials.gov Identifier:
NCT01311232
First received: March 6, 2011
Last updated: January 12, 2013
Last verified: January 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2013
  Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)